Atlas Trials

Geropharm

23 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Geropharm

RecordFirmDate
Open Randomized Study of Comparative Pharmacokinetics and Biosimilarity of GP40221 (GEROPHARM LLC, Russia) and Ozempic®. (NCT06497049)Geropharm2023-06-30
Evaluation of Insulin Glulisine (GP40321) Compared to Insulin Glulisine (Apidra® SoloStar®) in Type 1 Diabetes Mellitus Patients (NCT07070752)Geropharm2023-04-14
Study of Efficacy, Safety and Immunogenicity of GP40141 (GEROPHARM, Russia) in Patients With Immune Thrombocytopenia (NCT06497036)Geropharm2023-04-04
Double-blind, Randomized Comparative Cross-sectional Study of Pharmacodynamics and Pharmacokinetics of Drugs GP40141 (NCT05652595)Geropharm2022-06-03
Pharmacokinetics, Safety and Efficacy Study of GP30341 (GEROPHARM, Russia) (NCT05648799)Geropharm2022-03-17
Efficacy and Safety of GP40081 Сompared to NovoMix® 30 FlexPen® in Type 2 Diabetes Mellitus Patients (NCT04226105)Geropharm2020-01-20
Bioequivalence Study of GP30101 800 mg (GEROPHARM) Versus PREZISTA® 800 mg ("Jonson&Jonson", Russia) (NCT04268472)Geropharm2019-06-06
Efficacy and Safety of GP40071 Compared to NovoRapid® Penfill® in Type 1 Diabetes Mellitus Patients (NCT04079413)Geropharm2019-06-03
A Study to Compare Pharmacokinetics and Pharmacodynamics of GP-40081 to NovoMix® 30 Penfill® in Healthy Subjects (NCT04184492)Geropharm2019-04-15
A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Aspart to NovoRapid® Penfill® in Healthy Subjects (NCT04184466)Geropharm2018-10-18
Efficacy and Safety of Insulin RinGlar® Compared to Lantus® SoloStar® in Type 1 Diabetes Mellitus Patients (NCT04022993)Geropharm2018-07-04
Bioequivalence Study of Bosentan 125 mg Tablets Immediate Release (IR) Versus Tracleer® 125 mg Tablets IR In Healthy Subjects (NCT04101370)Geropharm2018-05-24
Efficacy and Safety of Insulin Lispro Biphasic 25 Compared to Humalog® Mix 25 in Type 2 Diabetes Mellitus Patients (NCT04023344)Geropharm2018-03-14
Comparative Study of Rinsulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (GEROPHARM LLC, Russia) and Humulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp Method (NCT04501250)Geropharm2017-10-23
A Study to Compare Pharmacokinetics and Pharmacodynamics of RinGlar® to Lantus® in Type 1 Diabetes Mellitus Patients (NCT04101383)Geropharm2017-10-16

Track Geropharm automatically

Every clearance here is in the API, with alerts when new ones post.